C1ORF144 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.295500E-02
Normal-vs-Stage2
2.397200E-01
Normal-vs-Stage3
1.711220E-01
Normal-vs-Stage4
9.483400E-01
Stage1-vs-Stage2
3.723200E-01
Stage1-vs-Stage3
9.536400E-01
Stage1-vs-Stage4
6.742000E-02
Stage2-vs-Stage3
4.321600E-01
Stage2-vs-Stage4
2.055000E-01
Stage3-vs-Stage4
2.061200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.084600E-01
Normal-vs-AfricanAmerican
4.199000E-01
Normal-vs-Asian
1.855780E-01
Caucasian-vs-AfricanAmerican
5.016000E-01
Caucasian-vs-Asian
5.848200E-01
AfricanAmerican-vs-Asian
3.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.212410E-01
Normal-vs-Female
3.510400E-01
Male-vs-Female
6.550500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.036000E-03
Normal-vs-Age(41-60Yrs)
4.992400E-01
Normal-vs-Age(61-80Yrs)
1.290160E-01
Normal-vs-Age(81-100Yrs)
1.807650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.396240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.429800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.688000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.695600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.222610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.179800E-02
Normal-vs-Daily Drinker
1.140390E-01
Normal-vs-Weekly Drinker
7.432800E-01
Normal-vs-Occasional Drinker
3.219200E-01
Normal-vs-Social Drinker
1.618590E-01
Non Drinker-vs-Daily Drinker
2.507200E-01
Non Drinker-vs-Weekly Drinker
1.588180E-01
Non Drinker-vs-Occasional Drinker
2.438300E-02
Non Drinker-vs-Social Drinker
1.026810E-01
Daily Drinker-vs-Weekly Drinker
3.856400E-01
Daily Drinker-vs-Occasional Drinker
2.044600E-01
Daily Drinker-vs-Social Drinker
5.121000E-01
Weekly Drinker-vs-Occasional Drinker
8.151400E-01
Weekly Drinker-vs-Social Drinker
5.929200E-01
Occasional Drinker-vs-Social Drinker
5.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.289200E-01
Normal-vs-Grade 2
7.949000E-01
Normal-vs-Grade 3
7.784600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.133600E-02
Grade 1-vs-Grade 3
9.346200E-02
Grade 1-vs-Grade 4
7.289200E-01
Grade 2-vs-Grade 3
4.168400E-01
Grade 2-vs-Grade 4
7.949000E-01
Grade 3-vs-Grade 4
7.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.563830E-01
Normal-vs-NonDiabetic
2.136000E-01
Diabetic-vs-NonDiabetic
6.940400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.253400E-01
Normal-vs-NoPancreatitis
2.116000E-01
Pancreatitis-vs-NoPancreatitis
5.884800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.795800E-02
Normal-vs-N1
2.834000E-01
N0-vs-N1
1.224970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.553200E-01
Normal-vs-TP53-NonMutant
7.337600E-02
TP53-Mutant-vs-TP53-NonMutant
8.924700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
